Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

[High-dose-rate brachytherapy in recurrent rectal cancer after conventional recurrence treatment].

Raabe NK, Sundfør K, Hole KH, Djupvik LH, Larsen SG, Dueland S.

Tidsskr Nor Laegeforen. 2014 Oct 28;134(20):1929-30. doi: 10.4045/tidsskr.14.1162. eCollection 2014 Oct 28. Norwegian. No abstract available.

2.

Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling.

Lando M, Wilting SM, Snipstad K, Clancy T, Bierkens M, Aarnes EK, Holden M, Stokke T, Sundfør K, Holm R, Kristensen GB, Steenbergen RD, Lyng H.

J Pathol. 2013 May;230(1):59-69. doi: 10.1002/path.4168. Epub 2013 Mar 14.

PMID:
23335387
3.

Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.

Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E.

Radiother Oncol. 2013 Apr;107(1):117-22. doi: 10.1016/j.radonc.2012.11.007. Epub 2013 Jan 17.

PMID:
23333024
4.

Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI.

Halle C, Andersen E, Lando M, Aarnes EK, Hasvold G, Holden M, Syljuåsen RG, Sundfør K, Kristensen GB, Holm R, Malinen E, Lyng H.

Cancer Res. 2012 Oct 15;72(20):5285-95. doi: 10.1158/0008-5472.CAN-12-1085. Epub 2012 Aug 13.

5.

Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.

Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e485-92. doi: 10.1016/j.ijrobp.2011.05.050. Epub 2011 Oct 17.

PMID:
22014954
6.

Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.

Halle C, Lando M, Svendsrud DH, Clancy T, Holden M, Sundfør K, Kristensen GB, Holm R, Lyng H.

Clin Cancer Res. 2011 Aug 15;17(16):5501-12. doi: 10.1158/1078-0432.CCR-11-0297. Epub 2011 Jul 7.

7.

Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer.

Halle C, Lando M, Sundfør K, Kristensen GB, Holm R, Lyng H.

Radiother Oncol. 2011 Oct;101(1):152-7. doi: 10.1016/j.radonc.2011.05.052. Epub 2011 Jun 15.

PMID:
21680035
8.

Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.

Lando M, Holden M, Bergersen LC, Svendsrud DH, Stokke T, Sundfør K, Glad IK, Kristensen GB, Lyng H.

PLoS Genet. 2009 Nov;5(11):e1000719. doi: 10.1371/journal.pgen.1000719. Epub 2009 Nov 13.

9.

Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas.

Lyng H, Sitter B, Bathen TF, Jensen LR, Sundfør K, Kristensen GB, Gribbestad IS.

BMC Cancer. 2007 Jan 17;7:11.

10.

Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.

Lyng H, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T.

BMC Genomics. 2006 Oct 20;7:268.

11.

Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix.

Lyng H, Beigi M, Svendsrud DH, Brustugun OT, Stokke T, Kristensen GB, Sundfør K, Skjønsberg A, De Angelis PM.

Int J Cancer. 2004 Sep 1;111(3):358-66.

12.

Gestational trophoblastic tumors in Norway, 1968-1997: patient characteristics, treatment, and prognosis.

Bjørge T, Abeler VM, Sundfør K, Tropé CG, Kaern J.

Gynecol Oncol. 2002 Oct;87(1):71-6.

PMID:
12468345
13.

Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging.

Lyng H, Vorren AO, Sundfør K, Taksdal I, Lien HH, Kaalhus O, Rofstad EK.

J Magn Reson Imaging. 2001 Dec;14(6):750-6.

PMID:
11747032
14.

Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy.

Lyng H, Vorren AO, Sundfør K, Taksdal I, Lien HH, Kaalhus O, Rofstad EK.

Int J Cancer. 2001 Jun 20;96(3):182-90.

16.

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument.

Tropé C, Kaern J, Hogberg T, Abeler V, Hagen B, Kristensen G, Onsrud M, Pettersen E, Rosenberg P, Sandvei R, Sundfor K, Vergote I.

Ann Oncol. 2000 Mar;11(3):281-8.

PMID:
10811493
18.

High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.

Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfør K, Rofstad EK, Mueller-Klieser W.

Cancer Res. 2000 Feb 15;60(4):916-21.

20.
21.
22.
23.
24.

Oxygen tension in human squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Lyng H, Sundfør K, Rofstad EK.

Adv Exp Med Biol. 1998;454:635-41. No abstract available.

PMID:
9889944
25.
26.

Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital.

Bjørge T, Engeland A, Sundfør K, Tropé CG.

Acta Obstet Gynecol Scand. 1998 Aug;77(7):777-81.

PMID:
9740528
27.
28.

Polarographic measurement of pO2 in cervix carcinoma.

Sundfør K, Lyng H, Kongsgård UL, Tropé C, Rofstad EK.

Gynecol Oncol. 1997 Feb;64(2):230-6.

PMID:
9038268
29.

Oxygen tension in primary tumours of the uterine cervix and lymph node metastases of the head and neck.

Lyng H, Sundfør K, Tanum G, Rofstad EK.

Adv Exp Med Biol. 1997;428:55-60. No abstract available.

PMID:
9500029
30.

Oxygen tension and vascular density in human cervix carcinoma.

Lyng H, Sundfør K, Tropé C, Rofstad EK.

Br J Cancer. 1996 Nov;74(10):1559-63.

31.

Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging.

Blomlie V, Rofstad EK, Talle K, Sundfør K, Winderen M, Lien HH.

AJR Am J Roentgenol. 1996 Nov;167(5):1205-10.

PMID:
8911181
32.
34.

Correlation of high lactate levels in human cervical cancer with incidence of metastasis.

Schwickert G, Walenta S, Sundfør K, Rofstad EK, Mueller-Klieser W.

Cancer Res. 1995 Nov 1;55(21):4757-9.

35.

Clinical stage I carcinoma of the cervix. Value of MR imaging in determining invasion into the parametrium.

Lien HH, Blomlie V, Iversen T, Tropé C, Sundfør K, Abeler VM.

Acta Radiol. 1993 Mar;34(2):130-2.

PMID:
8452717
36.

The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy.

Bye A, Kaasa S, Ose T, Sundfør K, Tropé C.

Clin Nutr. 1992 Jun;11(3):147-53.

PMID:
16839990
37.

[A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer].

Kaern J, Tropé C, Kjørstad KE, Nordal R, Sundfør K, Vergote I, Vossli S, Abeler V, Sandvei R.

Tidsskr Nor Laegeforen. 1990 Sep 10;110(21):2759-62. Norwegian.

PMID:
2219049
38.

Early complications of induced abortion in primigravidae.

Dalaker K, Sundfør K, Skuland J.

Ann Chir Gynaecol. 1981;70(6):331-6.

PMID:
7337407

Supplemental Content

Loading ...
Support Center